---
title: "Tuoshan: Net profit of 12.4292 million yuan in the first half of 2025, a year-on-year increase of 2.56%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254633362.md"
description: "Tuoshan announced that in the first half of 2025, the operating revenue was 324 million yuan, a year-on-year increase of 10.42%. The net profit was 12.4292 million yuan, a year-on-year increase of 2.56%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital"
datetime: "2025-08-26T12:36:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254633362.md)
  - [en](https://longbridge.com/en/news/254633362.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254633362.md)
generator: "portal-rs"
---

# Tuoshan: Net profit of 12.4292 million yuan in the first half of 2025, a year-on-year increase of 2.56%

Tuoshan Heavy Industry announced that in the first half of 2025, the operating revenue was 324 million yuan, a year-on-year increase of 10.42%. The net profit was 12.4292 million yuan, a year-on-year increase of 2.56%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital

### Related Stocks

- [001226.CN](https://longbridge.com/en/quote/001226.CN.md)

## Related News & Research

- [Shandong Hi-Speed New Energy unit signs RMB 1.23 billion wind power EPC contract](https://longbridge.com/en/news/296713454.md)
- [Guangdong Dtech shareholders to vote Sept. 15 on ending Rongcheng Hong Kong auditor engagement](https://longbridge.com/en/news/296359557.md)
- [Zephyr Introduces the Presrv™ Gourmet Clear Ice Machine](https://longbridge.com/en/news/296352842.md)
- [04:19 ETMacGregor to supply proven 165-tonne AHC crane for Ulstein SX121 newbuild](https://longbridge.com/en/news/296456488.md)
- [Sedana Medical says FDA accepts NDA for isoflurane ICU sedation system for review](https://longbridge.com/en/news/296306389.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**